Pharma · Private company
AstraZeneca
Track this companyFree. Adds AstraZeneca to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs35From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline35
- (Osimertinib cohort, single-arm, open-label separate cohort)Phase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone AcetatePhase 3 · Metastatic Castration-Sensitive Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- AnifrolumabPhase 3 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- AnifrolumabPhase 3 · Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- AS MDIPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- AZD0780Phase 3 · Heterozygous Familial HypercholesterolaemiaClinicalTrials.gov · fetched Nov 12, 2026
- Baxdrostat/dapagliflozinPhase 3 · Chronic Kidney Disease and HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- BDA MDIPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- BenralizumabPhase 3 · Eosinophilic Granulomatous VasculitisClinicalTrials.gov · fetched Nov 12, 2026
- BenralizumabPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 3 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- DarolutamidePhase 3 · Metastatic Castration-Sensitive Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Datopotamab deruxtecan (Dato-DXd)Phase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Non-small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVClinicalTrials.gov · fetched Nov 12, 2026
- DurvalumabPhase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 3 · Metastatic Castration-Sensitive Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- LenbelintidePhase 3 · Obesity or OverweightClinicalTrials.gov · fetched Nov 12, 2026
- MepolizumabPhase 3 · Eosinophilic Granulomatous VasculitisClinicalTrials.gov · fetched Nov 12, 2026
- Pegylated G-CSFPhase 3 · Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVClinicalTrials.gov · fetched Nov 12, 2026
- SaruparibPhase 3 · Metastatic Castration-Sensitive Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- SelumetinibPhase 3 · Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVClinicalTrials.gov · fetched Nov 12, 2026
- TezepelumabPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Torvutatug samrotecanPhase 3 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- VolrustomigPhase 3 · Locally Advanced Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
- AZD0120Phase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- AZD2936Phase 2 · Non-Small-Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AZD5148Phase 2 · Clostridioides Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AZD7798Phase 2 · Moderate to Severe Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SOCPhase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- AtorvastatinPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- AZD0543Phase 1 · Human Metapneumovirus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AZD1043Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- ElecoglipronPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- RosuvastatinPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian CancerPHASE3 · RECRUITING · started Sep 16, 2026ClinicalTrials.gov NCT07851025 · fetched Nov 12, 2026
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentPHASE3 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07691970 · fetched Nov 12, 2026
- Study of Safety and PK of AZD0543 in Healthy AdultsPHASE1 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07824622 · fetched Nov 12, 2026
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusPHASE3 · RECRUITING · started Aug 24, 2026ClinicalTrials.gov NCT07776509 · fetched Nov 12, 2026
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentPHASE3 · RECRUITING · started Jul 24, 2026ClinicalTrials.gov NCT07444567 · fetched Nov 12, 2026
- A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07534592 · fetched Nov 12, 2026
- A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusPHASE3 · RECRUITING · started Apr 13, 2026ClinicalTrials.gov NCT07430306 · fetched Nov 12, 2026
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.PHASE1 · RECRUITING · started Mar 30, 2026ClinicalTrials.gov NCT07511205 · fetched Nov 12, 2026
- A Study of AZD0120 in Autoimmune DiseasesPHASE1_PHASE2 · RECRUITING · started Jan 9, 2026ClinicalTrials.gov NCT07295847 · fetched Nov 12, 2026
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyPHASE2 · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT07285213 · fetched Nov 12, 2026
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsPHASE3 · RECRUITING · started Oct 31, 2025ClinicalTrials.gov NCT07291037 · fetched Nov 12, 2026
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFHPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT07000136 · fetched Nov 12, 2026
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressurePHASE3 · RECRUITING · started Mar 3, 2025ClinicalTrials.gov NCT06742723 · fetched Nov 12, 2026
- Phase IIa Study Evaluating AZD7798 in Crohn's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06450197 · fetched Nov 12, 2026
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPHASE3 · RECRUITING · started May 20, 2024ClinicalTrials.gov NCT06307665 · fetched Nov 12, 2026
- Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal AgentsPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 21, 2023ClinicalTrials.gov NCT06120491 · fetched Nov 12, 2026
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)PHASE3 · RECRUITING · started Sep 22, 2023ClinicalTrials.gov NCT06079671 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPHASE3 · RECRUITING · started Aug 24, 2023ClinicalTrials.gov NCT06023589 · fetched Nov 12, 2026
- SIRT With Tremelimumab and Durvalumab for Resectable HCCPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 21, 2023ClinicalTrials.gov NCT05701488 · fetched Nov 12, 2026
- Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 11, 2023ClinicalTrials.gov NCT05555732 · fetched Nov 12, 2026
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 2, 2022ClinicalTrials.gov NCT05047172 · fetched Nov 12, 2026
- A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 14, 2021ClinicalTrials.gov NCT04995523 · fetched Nov 12, 2026
- Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 29, 2019ClinicalTrials.gov NCT04157348 · fetched Nov 12, 2026
- Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 6, 2019ClinicalTrials.gov NCT03833154 · fetched Nov 12, 2026
- Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLCPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 25, 2013ClinicalTrials.gov NCT01933932 · fetched Nov 12, 2026